A phase 2 trial of niraparib plus bevacizumab maintenance therapy following first-line platinum-based chemotherapy with bevacizumab in advanced ovarian cancer: final analysis and overall survival results from OVARIO

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 95a02d536fba1590-LAX IP: 47.97.18.252 UTC time: 2025-07-04T17:00:07+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4